Table 2 Baseline demographics and clinical characteristics of patients in the training set and the validation set
Variable | Training set (N = 420) | Validation set (N = 180) | P value |
|---|---|---|---|
Continuous variables | |||
 Age, year | 50.00 (40.00,57.00) | 48.00 (37.75,61.00) | 0.376 |
 Interval from onset to diagnosis, day | 52.00 (33.00,159.50) | 46.50 (26.00,149.00) | 0.107 |
 ALT, U/L | 21.65 (15.57,32.92) | 22.15 (16.00,32.65) | 0.629 |
 AST, U/L | 22.15 (17.90,30.33) | 23.45 (18.95,31.23) | 0.173 |
 BMI, kg/m2 | 21.85 (19.84,23.94) | 21.48 (19.24,23.68) | 0.106 |
 CD4, cells/μL | 259.50 (111.50,384.50) | 243.50 (101.00,377.25) | 0.79 |
 TC, mmol/L | 4.15 (3.55,4.82) | 4.12 (3.48,4.80) | 0.559 |
 CR, μmol/L | 69.00 (61.00,77.00) | 69.00 (59.83,78.00) | 0.778 |
 FBG, mmol/L | 5.60 (5.10,6.09) | 5.37 (4.91,5.92) | 0.051 |
 HB, g/L | 136.00 (119.75,151.00) | 136.00 (117.75,152.25) | 0.956 |
 PLT, 109/L | 172.00 (137.00,213.25) | 167.50 (135.75,219.00) | 0.808 |
 TBIL, μmol/L | 10.25 (7.80,14.00) | 10.30 (6.80,13.40) | 0.203 |
 TG, mmol/L | 1.38 (1.03,1.87) | 1.32 (0.96,1.97) | 0.458 |
 WBC, 109/L | 5.20 (4.10,6.38) | 5.04 (4.01,6.38) | 0.475 |
Discrete variables | |||
 Gender, n(%) | |||
  Male | 386 (91.90) | 160 (88.89) | 0.276 |
  Female | 34 (8.10) | 20 (11.11) |  |
 Hepatitis B Virus, n(%) | |||
  Negative | 390 (92.86) | 170 (94.44) | 0.593 |
  Positive | 30 (7.14) | 10 (5.56) |  |
 Hepatitis C Virus, n(%) | |||
  Negative | 413 (98.33) | 178 (98.89) | 0.731 |
  Positive | 7 (1.67) | 2 (1.11) |  |
 Marital status, n(%) | |||
  Unmarried | 68 (16.19) | 42 (23.33) | 0.05 |
  Married | 352 (83.81) | 138 (76.67) |  |
 Shingles, n(%) | |||
  No | 375 (89.29) | 165 (91.67) | 0.458 |
  Yes | 45 (10.71) | 15 (8.33) |  |
 Infection route, n(%) | |||
  Homosexual transmission | 240 (57.14) | 98 (54.44) | 0.77 |
  Heterosexual transmission | 122 (29.05) | 54 (30.00) |  |
  Other transmission | 58 (13.81) | 28 (15.56) |  |
 Baseline TB, n(%) | |||
  No | 407 (96.90) | 175 (97.22) | 1.00 |
  Yes | 13 (3.10) | 5 (2.78) |  |
 WHO clinical stage, n(%) | |||
  I, II | 189 (45.00) | 75 (41.67) | 0.655 |
  III | 102 (24.29) | 43 (23.89) |  |
  IV | 129 (30.71) | 62 (34.44) |  |
 Continuous or intermittent fever, n(%) | |||
  No | 387 (92.14) | 167 (92.78) | 0.868 |
  Yes | 33 (7.86) | 13 (7.22) |  |
 Continuous diarrhea (> one month), n(%) | |||
  No | 397 (94.52) | 165 (91.67) | 0.202 |
  Yes | 23 (5.48) | 15 (8.33) |  |